Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness

Cholangiocarcinoma (CCA) is the second most common primary liver malignancy with extremely poor therapeutic outcome due to high drug resistance, widespread metastasis and lack of effective treatment options. CCA progression and metastasis are regulated by multiple biological factors including multip...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Ying, Wang, Yazhe, Li, Jing, Hang, Yu, Jaramillo, Lee, Wehrkamp, Cody J., Phillippi, Mary Anne, Mohr, Ashley M., Chen, Yi, Talmon, Geoffrey A., Mott, Justin L., Oupický, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134930/
https://www.ncbi.nlm.nih.gov/pubmed/30214622
http://dx.doi.org/10.7150/thno.26506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134930/
https://www.ncbi.nlm.nih.gov/pubmed/30214622
http://dx.doi.org/10.7150/thno.26506

Ejemplares similares